Literature DB >> 2365795

Bone marrow transplantation (BMT) for the syndrome of pigmentary dilution and lymphohistiocytosis (Griscelli's syndrome).

L C Schneider1, R S Berman, C R Shea, A R Perez-Atayde, H Weinstein, R S Geha.   

Abstract

We report the successful treatment of the syndrome of pigmentary dilution and immunodeficiency (Griscelli's syndrome) with allogeneic bone marrow transplantation. Griscelli's syndrome includes silvery hair, recurrent infections, hepatosplenomegaly, progressive neurologic deterioration, and lymphohistiocytosis and is uniformly fatal. We present a family in which four of seven children of consanguinous parents were affected. The affected children were all born with silvery hair. Microscopic examination of the hair showed large clumps of pigment in the hair shaft. Skin biopsy revealed an accumulation of melanosomes in the melanocytes. Three of the affected children were deceased before 20 months of age. Pathology of liver and lung in two of the siblings showed an infiltration of lymphocytes and histiocytes. Immunologic studies in one of these cases were notable for a decreased number of T cells and poor T-cell mitogen stimulation with concanavalin A (Con A) and pokeweed mitogen (PWM). Recently, a fourth sibling with silvery gray hair was referred to us at 3 months of age for evaluation. T-cell function studies were normal and she appeared in overall good health. Because of the expected fatal outcome, allogeneic bone marrow transplantation was performed at 4 months of age. Two years later the patient remains in excellent health. This suggests that cells of hematopoietic origin are responsible for the fatal outcome in Griscelli's syndrome and that bone marrow transplantation early in the course of the disease is an important modality for treatment of this syndrome.

Entities:  

Mesh:

Year:  1990        PMID: 2365795     DOI: 10.1007/bf00917914

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  15 in total

1.  Molecular genetic analysis of the dilute-short ear (d-se) region of the mouse.

Authors:  E M Rinchik; L B Russell; N G Copeland; N A Jenkins
Journal:  Genetics       Date:  1986-02       Impact factor: 4.562

2.  Allogeneic bone marrow transplantation for erythrophagocytic lymphohistiocytosis.

Authors:  A Fischer; N Cerf-Bensussan; S Blanche; F Le Deist; C Bremard-Oury; G Leverger; G Schaison; A Durandy; C Griscelli
Journal:  J Pediatr       Date:  1986-02       Impact factor: 4.406

3.  Partial albinism and immunodeficiency: ultrastructural study of haemophagocytosis and bone marrow erythroblasts in one case.

Authors:  E Brambilla; E Dechelette; P Stoebner
Journal:  Pathol Res Pract       Date:  1980-05       Impact factor: 3.250

4.  Natural cytotoxicity impairment in familial haemophagocytic lymphohistiocytosis.

Authors:  M Aricò; L Nespoli; R Maccario; D Montagna; F Bonetti; D Caselli; G R Burgio
Journal:  Arch Dis Child       Date:  1988-03       Impact factor: 3.791

5.  Busulfan and total body irradiation as antihematopoietic stem cell agents in the preparation of patients with congenital bone marrow disorders for allogenic bone marrow transplantation.

Authors:  R Parkman; J M Rappeport; S Hellman; J Lipton; B Smith; R Geha; D G Nathan
Journal:  Blood       Date:  1984-10       Impact factor: 22.113

6.  Use of VP-16-213 in the treatment of familial erythrophagocytic lymphohistiocytosis.

Authors:  C S Alvarado; G R Buchanan; T H Kim; G Zaatari; P Sartain; A H Ragab
Journal:  Cancer       Date:  1986-03-15       Impact factor: 6.860

7.  A new immunodeficiency disorder in humans involving NK cells.

Authors:  J C Roder; T Haliotis; M Klein; S Korec; J R Jett; J Ortaldo; R B Heberman; P Katz; A S Fauci
Journal:  Nature       Date:  1980-04-10       Impact factor: 49.962

8.  Mutations affecting pigmentation in man: I. Neuroectodermal melanolysosomal disease.

Authors:  B R Elejalde; J Holguin; A Valencia; E F Gilbert; J Molina; G Marin; L A Arango
Journal:  Am J Med Genet       Date:  1979

9.  A syndrome associating partial albinism and immunodeficiency.

Authors:  C Griscelli; A Durandy; D Guy-Grand; F Daguillard; C Herzog; M Prunieras
Journal:  Am J Med       Date:  1978-10       Impact factor: 4.965

10.  Bone-marrow transplantation for immunodeficiencies and osteopetrosis: European survey, 1968-1985.

Authors:  A Fischer; C Griscelli; W Friedrich; B Kubanek; R Levinsky; G Morgan; J Vossen; G Wagemaker; P Landais
Journal:  Lancet       Date:  1986-11-08       Impact factor: 79.321

View more
  10 in total

1.  Analysis of RAB27A gene in griscelli syndrome type 2: novel mutations including a deletion hotspot.

Authors:  Setareh Mamishi; Mohammad Hossein Modarressi; Babak Pourakbari; Banafshe Tamizifar; Fatemeh Mahjoub; Alireza Fahimzad; Soheila Alyasin; Mohamad Hassan Bemanian; Amir Ali Hamidiyeh; Mohammad Reza Fazlollahi; Mahmoud Reza Ashrafi; Anna Isaeian; Ghamartaj Khotaei; Mehdi Yeganeh; Nima Parvaneh
Journal:  J Clin Immunol       Date:  2008-03-19       Impact factor: 8.317

2.  Hematopoietic stem cell transplantation in children with Griscelli syndrome type 2: a single-center report on 35 patients.

Authors:  M Al-Mofareh; M Ayas; A Al-Seraihy; K Siddiqui; A Al-Jefri; I Ghemlas; H Alsaedi; H El-Solh; S Al-Sweedan; B Al-Saud; H Al-Mousa; H Al-Dhekri; R Arnaout; R Mohammed; S Al-Muhsen; A Al-Ahmari
Journal:  Bone Marrow Transplant       Date:  2020-04-14       Impact factor: 5.483

3.  Griscelli disease: genotype-phenotype correlation in an array of clinical heterogeneity.

Authors:  Ozden Sanal; Fúgen Ersoy; Ilhan Tezcan; Ayşe Metin; Leman Yel; Gaël Ménasché; Aytemiz Gürgey; Izzet Berkel; Geneviève de Saint Basile
Journal:  J Clin Immunol       Date:  2002-07       Impact factor: 8.317

4.  Griscelli syndrome.

Authors:  Sanjeev Rath; Vivek Jain; R K Marwaha; Amita Trehan; L S Rajesh; Vijay Kumar
Journal:  Indian J Pediatr       Date:  2004-02       Impact factor: 1.967

Review 5.  Evidence for defective Rab GTPase-dependent cargo traffic in immune disorders.

Authors:  Konrad Krzewski; Andrew R Cullinane
Journal:  Exp Cell Res       Date:  2013-06-26       Impact factor: 3.905

6.  Griscelli syndrome: characterization of a new mutation and rescue of T-cytotoxic activity by retroviral transfer of RAB27A gene.

Authors:  João C S Bizario; Jérôme Feldmann; Fabíola A Castro; Gaël Ménasché; Cristina M A Jacob; L Cristofani; Erasmo B Casella; Júlio C Voltarelli; Geneviève de Saint-Basile; Enilza M Espreafico
Journal:  J Clin Immunol       Date:  2004-07       Impact factor: 8.317

Review 7.  Chronic granulomatous disease and other disorders of neutrophil function.

Authors:  N R Kamani; A J Infante
Journal:  Clin Rev Allergy Immunol       Date:  2000-10       Impact factor: 10.817

8.  Griscelli syndrome type-3.

Authors:  Bela J Shah; Ashish K Jagati; Nilesh K Katrodiya; Sonal M Patel
Journal:  Indian Dermatol Online J       Date:  2016 Nov-Dec

9.  Griscelli Syndrome Type 3 in Siblings.

Authors:  Isha Gupta; Neha Dhankar; Surabhi Dayal; Sonia Chhabra
Journal:  Int J Trichology       Date:  2022-02-01

10.  Silvery grey hair: clue to diagnose immunodeficiency.

Authors:  Ms Sahana; S Sacchidanand; R Hiremagalore; Gs Asha
Journal:  Int J Trichology       Date:  2012-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.